• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Combating respiratory viruses with EHR data: Key use cases for life sciences and public health

Combating respiratory viruses with EHR data: Key use cases for life sciences and public health

by Truveta staff | Dec 10, 2024 | Research

“For the first time in the history of health, we have enough data at scale to dramatically advance innovation in healthcare” – Michael Slubowski, president & CEO, Trinity Health  Electronic health record (EHR) data is rapidly changing how life sciences,...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through October 2024 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through October 2024 

by Truveta staff | Nov 25, 2024 | Research

RSV-associated hospitalizations increased 191.5% throughout October 2024.   RSV-associated hospitalizations also increased in vulnerable populations with a 233.3% in infants and young children (aged 0-4) and 137.0% increase in older adults (65+); 2.4% of all...
How real-world data is transforming GLP-1 research for diabetes and obesity care

How real-world data is transforming GLP-1 research for diabetes and obesity care

by Truveta staff | Nov 7, 2024 | Research

GLP-1 medications are revolutionizing the way we treat type 2 diabetes and obesity. First discovered forty years ago, GLP-1 receptor agonists were initially approved for type 2 diabetes in 2005, with the first weight-loss-specific approval following in 2014. Flash...
Truveta Data used in new study exploring trends in colorectal cancer screening

Truveta Data used in new study exploring trends in colorectal cancer screening

by Truveta staff | Nov 4, 2024 | Research

Citation: Shaukat, Aasma MD, MPH et al. Real-World Adherence to Repeat Testing for Stool-Based Non-Invasive Colorectal Cancer Screening Tests Among Individuals With Average Risk. The American Journal of Gastroenterology 119(10S):p S265-S266, October...
New study finds youth obesity undertreated, despite new AAP guidelines

New study finds youth obesity undertreated, despite new AAP guidelines

by Truveta staff | Oct 30, 2024 | Research

Truveta Research in collaboration with a Harvard Medical School researcher explore use of obesity treatments in youth before and after new comprehensive guidelines for obesity management were published by the American Academy of Pediatrics (AAP). In a study of 329,357...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through early October 2024

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through early October 2024

by Truveta staff | Oct 28, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses decreased throughout September 2024 and into the first week of October. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased slightly by 2.9%...
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-world evidence on heart failure from GLP-1 and advanced CKD populations
  • Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval
  • Use of GLP-1 RAs following label expansion for patients with CVD and overweight or obesity

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.